INS and Hyperglycemia: When combined with an energy-restricted approach - which rapidly improves liver adiposity, liver insulin sensitivity, and fasting glucose [4] - the resultant reductions in hyperglycemia and liver adiposity could lead to both an alleviation of beta-cell stress and a healthier pattern of hepatokine secretion from the liver.